Background: There is very little information about the relationship between hyperuricemia, acute kidney injury (AKI) and in-hospital mortality.
cute kidney injury (AKI) is often encountered in patients who have coronary artery disease. Previous studies have documented the adverse prognostic impact of chronic renal insufficiency after percutaneous coronary intervention (PCI). 1,2 AKI after PCI is associated with increased 1-year mortality in patients undergoing PCI. [3] [4] [5] Chronic kidney disease, dehydration, diabetes mellitus (DM), advanced age and increased volume of contrast media are well-known risk factors for the development of AKI. 6-9 Metabolic syndrome, 10 hyperlipidemia, 10-12 hypoalbuminemia, 7,13,14 anemia 15, 16 and hyperuricemia 14 have recently been reported as new and possible risk markers for AKI after PCI. Hyperuricemia has been considered as a risk factor for hypertension, metabolic syndrome, DM, chronic kidney disease and ischemic heart disease. 17- 21 Furthermore, hyperuricemia is accompanied by enhanced synthesis of reactive oxygen species, activated renin-angiotensin-aldosterone system, increased endothelin-1 and inhibited nitric oxide system, which play a role in the pathogenesis of AKI. 19,21, 22 Hyperuricemia might be one of the factors deteriorating renal injury. 17 However, in the literature, there is very little information about the relationship between hyperuricemia and incidence of AKI/in-hospital mortality. Therefore, we retrieved the clinical and laboratory data from our interventional cardiology database and determined the effect of uric acid on the incidence of AKI and in-hospital mortality in patients treated with PCI.
Methods

Study Population
With a retrospective analysis of the medical records, we identified all patients who had coronary interventional intervention at a single center from August 2006 to December 2009. The average age of the patients was 61.01±12.24 years in males (n=777) and 69.67±8.98 years in females (n=470). No subgroups of patients (for example, those with acute myocar-Hyperuricemia and Acute Kidney Injury in PCI dial infarction (AMI) or shock) were excluded. PCI was performed using the standard technique. The specific type of revascularization procedure was at the discretion of the interventional cardiologist. All other treatments were at the discretion of the physicians, whether before, during or after the procedure. Exclusion criteria were as follows: (1) dialysis, (2) estimated glomerular filtration rate (eGFR) based on the Cockcroft-Gault formula 23 <10 ml · min -1 · 1.73 m -2 , (3) intravascular administration of iodinated contrast media within 72 h, and (4) a serum creatinine concentration of <0.4 mg/dl. After we examined the medical records of 1,373 patients, 126 patients were excluded based on exclusion criteria. 
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Definition and Materials
Hyperuricemia was defined as a serum uric acid concentration of greater than 7.0 mg/dl in men and 6.0 mg/dl in premenopausal women. 24 The relationship between uric acid and cardiovascular disease was found in terms of frank hyperuricemia (defined as more than 6 mg/dl in women and more than 7 mg/dl in men). 17 Based on the above 2 references, we defined hyperuricmeia as a serum uric acid concentration of ≥7 mg/dl for males and of ≥6.5 mg/dl for females because postmenopausal female patients were enrolled in our study. AKI was defined as an increase in serum creatinine of ≥0.5 mg/dl or ≥50% over baseline within 7 days of PCI. AMI was considered to have occurred if 2 of the following 3 criteria were met: typical chest pain for ≥30 min, troponin T elevation, development of ST-T wave changes and new Q waves or newly developed bundle branch block on electrocardiography. DM was defined as a fasting blood glucose concentration of ≥125 mg/dl, or a clinical diagnosis of diabetes with dietary, oral or insulin treatment. Hypoalbuminemia was defined as a serum albumin concentration of ≤3.5 g/dl. Multivessel coronary disease was defined as a coronary angiographic finding of more than 70% stenosis in ≥2 coronary arteries. We examined clinical (age, sex, body mass index, smoking, hypertension, DM, eGFR, AMI), laboratory (hemoglobin, hematocrit, albumin, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, glycated hemoglobin (HbA1c), serum creatinine, serum blood urea nitrogen (BUN), high sensitive C-reactive protein (hsCRP), N-terminal pro B-type natriuretic peptide, serum sodium, left ventricular ejection fraction (LVEF) and serum uric acid), procedual (the amount/type of contrast media and number of involved coronary vessels) characteristics. Serum uric acid was measured in 1,123 patients because of 124 missing values. Serum uric acid was measured regardless of fasting status in cases undergoing emergent PCI, while it was measured in fasting status in cases undergoing elective PCI. Iopromide (Ultravist, Bayer Health, 370 mg I/ml, osmolality 770 mOsm/kg water) and ioversol (Optiray, Mallinckrodt, Amersham Health, 320 mg I/ml, osmolality 702 mOsm/kg water) were used as non-ionic, low-osmolar contrast agents, and iodixanol (Vispaque, Amersham Health, 320 mg I/ml, osmolality 290 mOsm/kg water) was used as a non-ionic, isoosmolar contrast agent.
Statistical Analysis
Data are presented as mean ± SD or a percentage of the total. Continuous variables were compared by means of the Student's t-test; categorical variables were compared with the Pearson's χ2 test. Logistic regression (univariate analysis) was used to identify that AKI and hyperuricemia or uric acid were associated with in-hospital mortality after PCI. Univariate and multivariate logistic regression were used to identify the risk factors affecting AKI after PCI. The strength of the association between risk factors and AKI after PCI was expressed as odd ratios (OR) with 95% confidence intervals (CI). Models were developed with stepwise techniques and by considering variables that were clinically relevant.
Results
Comparison of Clinical, Laboratory and Procedural
Characteristics Between AKI and Non-AKI (Table 1) The study was carried out with 1,247 patients, and there were 777 men and 470 women. Comparison of clinical, biochemical and procedural characteristics between AKI and non-AKI are shown in Table 1 . Of the 1,247 patients in the study population, 51 (4.1%) experienced AKI after PCI, 15 of whom required hemodialysis. As seen in Table 1 , these patients were older; more often had DM, hyperuricemia, AMI and multivessel disease; showed lower values in baseline eGFR, albumin, hemoglobin, hematocrit and LVEF; and revealed higher values in baseline creatinine, baseline BUN, hsCRP, amount of contrast media, fasting blood glucose, HbA1c and uric acid. In-hospital mortality was 19.6% (10 of 51) in the AKI inividuals and 0.8% (10 of 1,186) in the non-AKI.
Characteristics Between Elective PCI and Emergent PCI (Table 2) We analyzed the data, divided by emergent and elective PCI group. As seen in Table 2 , there was no statistical difference in serum uric acid concentration, hyperuricemia, BUN, creatinine, eGFR, contrast volume, albumin, and mulitvessel disease between emergent and elective PCI. However, statistical significance was shown in age, BMI, DM, fasting blood sugar, hemoglobin, hematocrit, glycated hemoglobin, hsCRP, Tables 1,3 . Hyperuricemia and Acute Kidney Injury in PCI LVEF, AMI, AKI, and in-hospital mortality.
Predictors of AKI (Tables 3,4)
We used univariate analysis to study different possible risk factors for the development of AKI. Univariate variables associated with AKI were age, baseline eGFR, baseline creatinine and BUN, DM, AMI, dose of contrast media, hemoglobin, hematocrit, hyperuricemia, uric acid, fasting blood glucose, HbA1c, hsCRP, hypoalbuminemia, LVEF and multivessel involvement ( Table 3) . We performed multivariate analysis for the variables that had a statistical significance in univariate analysis. Multivariate analysis showed that the significant predictors of AKI after PCI were a baseline eGFR of <60 ml · min -1 · 1.73 m -2 , AMI, DM, hyperuricemia, amount of contrast media and hemoglobin ( Table 4) .
Incidence of AKI in the Study Groups Based on Baseline eGFR and Diabetic Status
The observed incidence of AKI after PCI was related to baseline eGFR and the presence of diabetes and hyperuricemia. Incidence of AKI was 0.6% (4/636) in non-diabetic patients with a baseline eGFR of ≥60 ml · min -1 · 1.73 m -2 (group A), 2.1% (6/280) in diabetic patients with a baseline eGFR of ≥60 ml · min Table 4) . Group 4 had a higher incidence of AKI than group 3 (OR, Figure. Comparison of serum uric acid concentration between nondeath and death group. Death group showed a higher serum uric acid concentration than non-death group (6.042±2.67 vs. 5.169±1.57 mg/dl, P= 0.018) Table 6 ) In-hospital death group had a higher serum uric acid concentration than in-hospital survivor group (6.042±2.67 mg/dl vs. 5.169±1.57, P=0.018) (Figure) . As shown in Table 6 , inhospital mortality increased in the group developing AKI, hyperuricemic group and patients with a high serum uric acid concentration.
Discussion
This study indicated that hyperuricemia or high baseline serum uric acid increased the incidence of AKI and in-hospital mortality after PCI. Although the overall incidence of AKI after PCI was low (4.1%), diabetic or hyperuricemic patients with chronic renal insufficiency (a baseline eGFR of <60 ml · min -1 · 1.73 m -2 ) was at high risk of AKI, and AKI portended a very high risk of death in the hospital. In previous studies, the predictors of AKI were decreased eGFR, diabetes with chronic kidney disease, increased dose of contrast media, older age, anemia, drug toxicity, multivessel coronary involvement, conditions resulting in a low effective circulating volume such as cardiogenic shock, use of an intra-aortic balloon pump, hypotension, congestive heart failure and AMI. 4,6,7,25-32 Our results were consistent with previous outcome studies documenting a higher incidence of AKI in decreased eGFR or pre-existing renal failure, diabetes with chronic kidney disease, AMI, low level of hemoglobin, older age, increased dose of contrast media, depressed LVEF and multivessel involvement. Therefore, although our study had a retrospective design, it is inferred that our study model and results might be relevant and significant. Notably, in multivariate analysis, the most powerful predictors of AKI were pre-existing renal failure, DM, AMI, baseline hemoglobin, dose of contrast media and hyperuricemia. The mechanism of a higher incidence of AKI in AMI seems to be associated with hemodynamic instability. Since AMI is an emergent condition, adequate hydration before PCI is seldomly performed. The incidences of AKI reported in previous studies were generally lower than that in our study. 6,7,25-31 Most of these studies were performed among stable patients, whereas those who were critically ill or in shock, such as AMI, was included in our study. Therefore, to favorably influence prognosis therapeutic maneuvers that are directed both at achieving hemodynamic stability and at preventing multiorgan failure are probably needed.
In this study, the results of multivariate analysis showed that hyperuricemia was a powerful predictor of AKI. Several epidemiological studies have shown that hyperuricemia is associated with cardiovascular events, metabolic syndrome, stroke, hypertension, proteinuria and dyslipidemia. 17,21, 33 Also, there are several mechanisms by which uric acid contributes to AKI. 34 However, to date, very little information is available in the literature on the role of hyperuricemia as a predictor of AKI after PCI. Hyperuricemia inhibits the nitric oxide system in the kidneys and increases endothelin-1 concentrations. 19,22, 34 An increase in endothelin-1 and decrease in nitric oxide contribute to vasoconstriction, which reduces renal medullary blood flow. 35,36 In our study, the incidence of AKI after PCI was increased markedly in diabetic or hyperuricemic patients with a baseline eGFR of <60 ml · min -1 · 1.73 m -2 . Patients who are at higher risk of developing AKI, such as those with DM or renal failure, have an impaired endothelial function. At the same time, impaired endothelial function is an important finding of hyperuricemia. 17,19- 21 The current literature supports the role of hyperuricemia as an independent, modifiable marker of cardiovascular damage and an independent predictor of cardiovascular event. 18,20, 37 Mehran et al 38 evaluated a total of 5,571 patients who underwent PCI for the detection of risk factors for AKI, and have demonstrated that multivessel coronary involvement is only a univariate predictor of AKI (P=0.003), which is consistent with our results. In patients with multivessel coronary involvement, other vessels in the body, such as the renal artery, can be involved. If the renal artery is involved, renal blood supply might be decreased and the kidneys could be more susceptible to AKI. This might help to explain why hyperuricemic patients were more susceptible to developing AKI in our study.
However, previous studies have reported that endothelial function improves in patients with hyperuricemia and heart failure or diabetes who received allopurinol but not in those who received other uric acid-lowering drugs. 39, 40 Allopurinol is not a safe drug because its hypersensitivity reactions can be fatal and there is no sufficient evidence to support treatment of asymptomatic hyperuricemia with this drug, Further studies are needed to determine whether individuals with asymptomatic hyperuricemia should be treated with allopurinol.
The present study has several limitations. First, this is a retrospective study at a single center, and researchers were not blinded to the clinical and laboratory information including variables of uric acid and renal function. Second, even after multivariate analysis, hyperuricemia remained an independent predictor of AKI; however, multivariate models cannot entirely account for the baseline differences, and adjusted effects still might be influenced by residual confounding factors. Finally, because the association of uric acid/hyperuricemia and in-hospital mortality was evaluated only by a univariate model, statistical power might be low and confoundable. However, because our results are consistent with those of previous studies in many variables and are adequately adjusted by multivariate logistic regression, it is believed that hyperuricemia is a powerful predictor of AKI. At the same time, our study had important implications that hyperuricemia might impact in-hospital mortality after PCI.
Conclusions
It is clear that AKI develops due to multiple risk factors. AKI patients had a high incidence of vascular complications and increased in-hospital mortality. We found that serum uric acid is independently associated with an increased risk of AKI in patients with coronary artery disease treated with PCI and that AKI and hyperuricemia might impact in-hospital mortality after PCI. We believe that our results have clinical implications because hyperuricemia is identified as a modifiable risk factor. Therefore, the serum uric acid concentration Tables 1,3 . Hyperuricemia and Acute Kidney Injury in PCI before PCI seems to be useful to assess the risk for the development of AKI and in-hospital mortality.
